2022
DOI: 10.1080/08880018.2022.2101723
|View full text |Cite
|
Sign up to set email alerts
|

Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Family studies, of which trio or quad are the simplest type, in complex diseases such as autism and psychiatric disorders (Iossifov et al 2014); (Iossifov et al 2012); (McCarthy et al 2014); (Fromer et al 2014); (Lelieveld et al 2016) have shown the power of utilizing a family study design to filter shared variants with little impact on pathogenicity, while highlighting significant differences that may be causative. In fact, utilization of family structure has successfully uncovered drivers in pediatric cancers (Kuhlen et al 2019); (Derpoorter et al 2023). This may be particularly informative in early-onset cancer probands, who in addition to de novo mutations which have been found to be potentially disruptive and implicated in a variety of diseases (Acuna-Hidalgo, Veltman, and Hoischen 2016), may have inherited separate variants from each unaffected parent that act in concert to drive carcinogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Family studies, of which trio or quad are the simplest type, in complex diseases such as autism and psychiatric disorders (Iossifov et al 2014); (Iossifov et al 2012); (McCarthy et al 2014); (Fromer et al 2014); (Lelieveld et al 2016) have shown the power of utilizing a family study design to filter shared variants with little impact on pathogenicity, while highlighting significant differences that may be causative. In fact, utilization of family structure has successfully uncovered drivers in pediatric cancers (Kuhlen et al 2019); (Derpoorter et al 2023). This may be particularly informative in early-onset cancer probands, who in addition to de novo mutations which have been found to be potentially disruptive and implicated in a variety of diseases (Acuna-Hidalgo, Veltman, and Hoischen 2016), may have inherited separate variants from each unaffected parent that act in concert to drive carcinogenesis.…”
Section: Introductionmentioning
confidence: 99%